Top Updates Back
Sumitomo Pharma Switzerland GmbH
Bangladesh
Manufacturing and sales of pharmaceuticals
Development of regenerative medicine and cell therapy products
Research and development of regenerative medicine and cell therapy
Development of digital health solutions and healthcare services
Office Location:
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Sumitomo Chemical Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Parent
Sumitomo Pharma Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Parent
Altavant Sciences GmbH
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Enzyvant Therapeutics GmbH
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Enzyvant Therapeutics, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Myovant Sciences GmbH
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Myovant Sciences, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Sumitovant Biopharma, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Urovant Sciences GmbH
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Urovant Sciences, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Sumitomo Pharma America, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Pfizer Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
BehaVR, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Drawbridge Health, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Merck Sharp & Dohme Corp.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Spirovant Sciences, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
Takeda Pharmaceutical Company Limited
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Tsubota Laboratory, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

10 entries
DateDescription
1897-05-14 旧 大日本製薬 1897年 （明治30年）5月14日設立。大阪・道修町の有力薬業家21名により、大阪製薬 株式会社が設立される。
1984-02-06 旧 住友製薬 1984年 （昭和59年）2月6日設立。住友化学工業株式会社（現住友化学株式会社）の 医薬事業の研究、開発、製造部門と、住友化学の 医薬品の販売総代理店であった稲畑産業株式会 社の医薬販売部門を継承して、住友製薬株式会社 が設立される。
1993 1993年 高血圧症・狭心症治療薬「アムロジン®」新発売
1995 1995年 カルバペネム系抗生物質製剤「メロペン®」新発売
1999 1999年 住友製薬アメリカリミテッド設立
2003 2003年 住友制葯（蘇州）有限公司設立
2013 2013年 シンガポールに子会社（スミトモファーマ・アジア・パシフィック・プライベート・リミテッド）を設立
2014 2014年 再生医療製品事業に関する合弁会社（株式会社サイレジェン）を設立
2020 2020年 非定型抗精神病薬「ラツーダ®」 日本で新発売
2023-07-01 2023年7月1日付で米国グループ会社の再編により発足
+ Loaded when opened
✅
2026-09-21 18:05 (Model: gpt-4.1-nano )
↑